Technical Analysis for AKYA - Akoya BioSciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.01 | -2.91% | -0.12 |
AKYA closed down 2.91 percent on Monday, April 15, 2024, on 84 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Downtrend | Bearish | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Reached Oversold | Weakness | -2.91% | |
| Oversold Stochastic | Weakness | -2.91% | |
| NR7 | Range Contraction | -6.74% | |
| Narrow Range Bar | Range Contraction | -6.74% | |
| Inside Day | Range Contraction | -6.74% | |
| Oversold Stochastic | Weakness | -6.74% | |
| Lower Bollinger Band Walk | Weakness | -6.74% | |
| Inside Day | Range Contraction | -6.74% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 21 hours ago |
| Down 3% | about 22 hours ago |
| Down 2 % | about 23 hours ago |
| Fell Below Previous Day's Low | about 23 hours ago |
| Down 1% | about 23 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2024
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Disease Imaging
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Disease Imaging
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.8 |
| 52 Week Low | 3.04 |
| Average Volume | 184,647 |
| 200-Day Moving Average | 5.01 |
| 50-Day Moving Average | 5.11 |
| 20-Day Moving Average | 4.55 |
| 10-Day Moving Average | 4.27 |
| Average True Range | 0.29 |
| RSI (14) | 31.97 |
| ADX | 25.83 |
| +DI | 8.41 |
| -DI | 22.40 |
| Chandelier Exit (Long, 3 ATRs) | 4.38 |
| Chandelier Exit (Short, 3 ATRs) | 4.83 |
| Upper Bollinger Bands | 5.18 |
| Lower Bollinger Band | 3.91 |
| Percent B (%b) | 0.08 |
| BandWidth | 27.93 |
| MACD Line | -0.26 |
| MACD Signal Line | -0.24 |
| MACD Histogram | -0.0245 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.30 | ||||
| Resistance 3 (R3) | 4.31 | 4.23 | 4.25 | ||
| Resistance 2 (R2) | 4.23 | 4.16 | 4.22 | 4.23 | |
| Resistance 1 (R1) | 4.12 | 4.11 | 4.08 | 4.11 | 4.22 |
| Pivot Point | 4.04 | 4.04 | 4.02 | 4.03 | 4.04 |
| Support 1 (S1) | 3.93 | 3.97 | 3.89 | 3.92 | 3.80 |
| Support 2 (S2) | 3.85 | 3.92 | 3.84 | 3.79 | |
| Support 3 (S3) | 3.74 | 3.85 | 3.77 | ||
| Support 4 (S4) | 3.73 |
